SAGE THERAPEUTICS INC

CUSIP: 78667J108 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 41,682 Value ($000) $0 Avg Close — Range —
Q1 2025
Shares 67,746 Value ($000) $1 Avg Close — Range —
Q4 2024
Shares 17,674 Value ($000) $0 Avg Close — Range —
Q2 2024
Shares 78,749 Value ($000) $1 Avg Close — Range —
Q1 2024
Shares 11,655 Value ($000) $0 Avg Close — Range —
Q4 2023
Shares 70,379 Value ($000) $2 Avg Close — Range —
Q1 2023
Shares 10,721 Value ($000) $0 Avg Close — Range —
Q3 2022
Shares 13,557 Value ($000) $531 Avg Close — Range —
Q2 2022
Shares 18,750 Value ($000) $606 Avg Close — Range —
Q4 2021
Shares 26,035 Value ($000) $1,108 Avg Close — Range —
Q3 2021
Shares 8,371 Value ($000) $371 Avg Close — Range —
Q2 2021
Shares 17,381 Value ($000) $987 Avg Close — Range —
Q4 2020
Shares 6,487 Value ($000) $561 Avg Close — Range —
Q3 2020
Shares 4,744 Value ($000) $290 Avg Close — Range —
Q1 2020
Shares 21,374 Value ($000) $614 Avg Close — Range —
Q4 2019
Shares 6,167 Value ($000) $445 Avg Close — Range —
Q2 2015
Shares 5,600 Value ($000) $409 Avg Close — Range —